Labcorp (LH)
(Delayed Data from NYSE)
$199.35 USD
-3.61 (-1.78%)
Updated Jul 9, 2024 04:00 PM ET
After-Market: $199.35 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth B Momentum B VGM
Price, Consensus and EPS Surprise
LH 199.35 -3.61(-1.78%)
Will LH be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for LH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for LH
Here's Why Labcorp (LH) is a Strong Value Stock
Here's Why Labcorp (LH) is a Strong Value Stock
LH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is It the Right Time to Hold Labcorp (LH) in Your Portfolio?
Why Labcorp (LH) is a Top Value Stock for the Long-Term
Why Labcorp (LH) is a Top Value Stock for the Long-Term
Other News for LH
NOWDiagnostics Secures $22.5 Million in Series B Funding
Analysts Offer Insights on Healthcare Companies: EyePoint Pharmaceuticals (EYPT), Praxis Precision Medicines (PRAX) and Laboratory (LH)
Laboratory Corporation: Limited Upside Visibility, Reiterate Hold
Interesting LH Put And Call Options For February 2025
Labcorp Launches Global Trial Connect to Accelerate Clinical Trials